小鼠抗PSMD2单克隆抗体

Background:

The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the non-ATPase subunits of the 19S regulator lid. In addition to participation in proteasome function, this subunit may also participate in the TNF signalling pathway since it interacts with the tumor necrosis factor type 1 receptor. A pseudogene has been identified on chromosome 1. [provided by RefSeq].

Applications:

WB, IHC, IF

Name of antibody:

PSMD2

Immunogen:

Fusion protein of human PSMD2

Full name:

proteasome 26S subunit, non-ATPase 2 (PSMD2), transcript variant 1

Synonyms:

P97; RPN1; S2; TRAP2

SwissProt:

Q13200

IHC positive control:

human kidney tissue and human pancreas tissue; human lymphoma tissue

IHC Recommend dilution:

30-150

WB Predicted band size:

100 kDa

WB Positive control:

HepG2, Hela, SVT2, A549, COS7, Jurkat, MDCK, PC12, MCF-7 cell lysates

WB Recommended dilution:

1000-5000